Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis

Annals of the Rheumatic Diseases

Volumn 68, Issue 3, 2009, Pages 408-411

  Manetti, M ^a   Liakouli, V ^b   Fatini, C ^a   Cipriani, P ^b   Bonino, C ^c   Vettori, S ^c   Guiducci, S ^a   Montecucco, C ^c   Abbate, R ^a   Valentini, G ^d   Matucci Cerinic, M ^a   Giacomelli, R ^b   Ibba Manneschi, L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; STROMAL CELL DERIVED FACTOR 1;

ADULT; ALLELE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCLERODERMA; SKIN EXAMINATION; SKIN ULCER; SYSTEMIC SCLEROSIS;

ADULT; AGED; AUTOANTIBODIES; CHEMOKINE CXCL12; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICROVESSELS; MIDDLE AGED; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SCLERODERMA, SYSTEMIC; SKIN ULCER;

EID: 61449251671     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.098277     Document Type: Article

References (16)

1. Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotlc disorder. J Clin Invest 2007;117:557-67.
2. Kahaleh BM. Vascular involvement in systemic sclerosis. Clin Exp Rheumatol 2004;22(Suppl33):S19-23.
3. Guiducci S, Giacomelli R, Cerinlc MM. Vascular complications of scleroderma. Autoimmun Rev 2007;6:520-3.
4. Distler JH, Allanore Y, Avouac J, Giacomelli R, Guiducci S, Moritz F, et al. EUSTAR statement and recommendations on endothelial precursor cells. Ann Rheum Dis Published Online First: 23 July 2008. doi:10.1136/ard.2008.091918.
5. Salcedo R, Oppenheim JJ. Role of chemokines in angiogenesls: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses. Microcirculation 2003;10:359-70.
6. Kucia M, Jankowski K, Reca R, Wysoczynskl M, Bandura L, Allendorf DJ, et al. CXCR4-SDF-1 signalling, locomotion, Chemotaxis and adhesion. J Mol Histol 2004;35:233-45.
7. De Falco E, Porcelli D, Torella AR, Straino S, Iachlninoto MG, Orlandi A, et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004;104:3472-82.
8. Cipriani P, Milia AF, Liakouli V, Pacini A, Manetti M, Marrelli A, et al. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 In the skin and endothelial cells of systemic sclerosis patients: pathogenetic implications. Arthritis Rheum 2006;54:3022-33.
9. Cipriani P, Guiducci S, Miniatl I, Cinelli M, Urbani S, Marrelli A, et al. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 2007;56:1994-2004.
10. Magierowska M, Lepage V, Boubnova L, Carcassi C, de Juan D, Djoulah S, et al. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3'A variant In healthy Individuals from different populations. Immunogenetics 1998;48:417-9.
11. Kimura R, Nishloka T, Soemantri A, Ishida T. Allele-speciflc transcript quantification detects haplotyplc variation in the levels of the SDF-1 transcripts. Hum Mol Genet 2005;14:1579-85.
12. Benboubker L, Watier H, Carlon A, Georget MT, Desbois I, Colombat P, et al. Association between the SDF1-3'A allele and high levels of CD34+ progenitor cells mobilized into peripheral blood In humans. Br J Haematol 2001;113:247-50.
13. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
14. Valentini G, Medsger TA Jr, Silman AJ, Bombardiert S. The assessment of the patient with systemic sclerosis. Clin Exp Rheumatol 2003;21 (Suppl 29):S2-48.
15. Distler O, Behrens F, Pittrow D, Huscher D, Denton CP, Foeldvari I, et al. Defining appropriate outcome measures In pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis. Arthritis Rheum 2008;59:867-75.
16. Allanore Y, Wipff J, Kahan A, Boileau C. Genetic basis for systemic sclerosis. Joint Bone Spine 2007;74:577-83.